Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice.
Theiler's murine encephalomyelitis virus (TMEV)-induced immune-mediated demyelinating disease in susceptible mouse strains has been extensively investigated as a relevant model for human multiple sclerosis. Previous investigations of antiviral T-cell responses focus on immune responses to viral capsid proteins, while virtually nothing is reported on immune responses to nonstructural proteins. In this study, we have identified noncapsid regions recognized by CD4(+) T cells from TMEV-infected mice using an overlapping peptide library. Interestingly, a greater number of CD4(+) T cells recognizing an epitope (3D(21-36)) of the 3D viral RNA polymerase, in contrast to capsid epitopes, were detected in the CNS of TMEV-infected SJL mice, whereas only a minor population of CD4(+) T cells from infected C57BL/6 mice recognized this region. The effects of preimmunization and tolerization with these epitopes on the development of demyelinating disease indicated that capsid-specific CD4(+) T cells are protective during the early stages of viral infection, whereas 3D(21-36)-specific CD4(+) T cells exacerbate disease development. Therefore, protective versus pathogenic CD4(+) T-cell responses directed to TMEV appear to be epitope dependent, and the differences in CD4(+) T-cell responses to these epitopes between susceptible and resistant mice may play an important role in the resistance or susceptibility to virally induced demyelinating disease.
Jin
Young-Hee
YH
Department of Microbiology-Immunology and Neuroscience Institute, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611, USA.
Kang
Bongsu
B
Kim
Byung S
BS
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D018188:Cardiovirus Infections / Q000276:immunology / Q000821:virology; D002460:Cell Line; D012321:DNA-Directed RNA Polymerases / Q000235:genetics / Q000276:immunology*; D003711:Demyelinating Diseases / Q000276:immunology / Q000473:pathology / Q000821:virology; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D010455:Peptides / Q000235:genetics / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology; D017945:Theilovirus / Q000276:immunology*; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology*
D000939:Epitopes; D010455:Peptides; D014764:Viral Proteins; D012321:DNA-Directed RNA Polymerases
J Virol. 1997 Jul;71(7):5244-50
9188592
J Virol. 2008 Dec;82(23):11545-54
18815294
Eur J Immunol. 1993 Sep;23(9):2287-93
8370406
Nat Med. 1997 Dec;3(12):1394-7
9396611
J Immunol. 1997 Jan 1;158(1):127-35
8977183
J Neurol Sci. 1976 Nov;30(1):201-7
978224
J Immunol. 1995 Nov 1;155(9):4497-503
7594613
J Exp Med. 1998 Jun 15;187(12):2055-63
9625765
Mol Immunol. 1994 Aug;31(11):803-12
7519304
Vaccine. 2003 Oct 1;21(27-30):4261-9
14505908
J Immunol. 1995 Jul 15;155(2):947-57
7608570
J Virol. 1998 Jul;72(7):6169-74
9621084
Adv Exp Med Biol. 1993;342:413-8
7911644
J Immunol. 1985 Sep;135(3):2145-8
2991380
J Virol. 1998 May;72(5):4515-9
9557751
Ann Allergy. 1990 May;64(5):433-44
2186672
Neurology. 1984 Aug;34(8):1117-9
6087205
Eur J Immunol. 2006 Aug;36(8):2106-15
16761311
Eur J Immunol. 2004 Oct;34(10):2730-9
15368289
J Neurovirol. 2001 Oct;7(5):409-20
11582513
J Virol. 2007 Jun;81(12):6584-93
17428853
J Neuroimmunol. 2001 Jul 2;117(1-2):166-70
11431017
J Immunol. 2002 Apr 15;168(8):4221-30
11937584
Virology. 2004 May 1;322(2):264-75
15110524
J Immunol. 2006 Nov 15;177(10):6705-12
17082583
J Virol. 1998 Feb;72(2):1020-7
9444995
Arch Immunol Ther Exp (Warsz). 2000;48(5):373-9
11140464
J Virol. 1997 Jul;71(7):5361-5
9188606
J Virol. 1995 Nov;69(11):7315-8
7474161
Ann Neurol. 1983 Apr;13(4):426-33
6340596
J Neuropathol Exp Neurol. 1993 Mar;52(2):95-105
8440999
Int Immunol. 1994 May;6(5):721-30
8080842
Immunology. 1995 Jun;85(2):190-7
7543873
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14124-9
18768820
Eur J Immunol. 1993 Jan;23(1):46-55
8419186
J Immunol. 1994 Jan 15;152(2):908-18
7904291
J Neuroimmunol. 2001 Aug 30;118(2):256-67
11498260
Nat Genet. 1993 Sep;5(1):87-91
8220433
J Neurosci. 1998 Sep 15;18(18):7306-14
9736651
Nat Med. 1998 Feb;4(2):187-193
9461192
J Immunol. 1993 Jul 1;151(1):266-76
8326128
J Virol. 2002 Jul;76(13):6577-85
12050370
PLoS Pathog. 2007 Aug 24;3(8):e124
17722981
J Virol. 2002 Apr;76(7):3125-34
11884537
J Neuroimmunol. 2001 Jun 1;116(2):125-35
11438167
J Immunol. 1995 Nov 15;155(10):5003-10
7594507
J Virol. 1993 Jan;67(1):589-92
8416386
J Virol. 2007 Nov;81(21):11690-702
17715222
J Immunol. 1994 Nov 15;153(10):4508-19
7525707
J Immunol. 1984 Apr;132(4):1821-5
6699403
J Exp Med. 2009 Feb 16;206(2):313-28
19204109